Skip to content
10-Q

Quarterly Report

ANTIVIRAL TECHNOLOGIES, INC.

0001137050-13-000156

← back to feed
Filed
May 9, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2013 · Mar 31, 2013 150M sh
Operating Cash Flow Q1 2013 · Mar 31, 2013 −$1.22M
Operating Cash Flow Q1 2013 · Mar 31, 2012 −$43.94K
Cash And Equivalents Q1 2013 · Mar 31, 2013 $553
Cash And Equivalents Q1 2013 · Mar 31, 2012 $1.82K
Cash And Equivalents Q1 2013 · Dec 31, 2011 $3.94K
Stockholders Equity Q1 2013 · Mar 31, 2013 −$2.38M
Stockholders Equity Q1 2013 · Dec 31, 2012 −$2.3M
Total Liabilities Q1 2013 · Mar 31, 2013 $2.88M
Total Liabilities Q1 2013 · Dec 31, 2012 $2.79M
Current Assets Q1 2013 · Mar 31, 2013 $555
Current Assets Q1 2013 · Dec 31, 2012 $701
Total Assets Q1 2013 · Mar 31, 2013 $492.22K
Total Assets Q1 2013 · Dec 31, 2012 $485.2K
Sga Expense Q1 2013 · Mar 31, 2013 $2.21M
Sga Expense Q1 2013 · Mar 31, 2012 $84.82K
Net Income Q1 2013 · Mar 31, 2013 −$2.38M
Net Income Q1 2013 · Mar 31, 2012 −$90.14K